Keros Therapeutics, Inc. (KROS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4923271013
Keros Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 243.86 m USD |
| Operating income | 67.57 m USD |
| EBIT | 91.90 m USD |
| Net income | 87.01 m USD |
| Diluted EPS – continuing operations | 2.30 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Keros Therapeutics, Inc.
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis; and elritercept to target TGF-ß signaling pathways to address diseases that arise from ineffective hematopoiesis in Phase 3 clinical trials for Myelodysplastic Syndromes and Phase 2 clinical trials for Myelofibrosis. The company has collaboration and license agreements with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept; and Takeda Pharmaceuticals U.S.A., Inc. to develop, manufacture, and commercialize elritercept and certain derivative compounds. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
More stocks
- Clarus Corp (CLAR)
- OE Solutions Co. Ltd (138080.KQ)
- ANGEL ROBOTICS Co., Ltd. (455900.KQ)
- Mastersystem Infotama Tbk. (MSTI.JK)
- Sinphar Pharmaceutical Co Ltd (1734.TW)
- Brogent Technologies (5263.TWO)
- SillaJen Inc (215600.KQ)
- MPC Muenchmeyer Petersen Capital (MPCK.DE)
- TREDEGAR CORP (TG)
- Chlitina Holding Ltd (4137.TW)
- Aumann (AAG.DE)
- Ta Chia Yung Ho Machine Industry Co Ltd (2221.TWO)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.